In a research project that has real implications for their regular laboratory work, a pair of physicists at Brown University ...
Genitourinary (GU) cancers, including prostate, bladder, renal and testicular malignancies, represent a heterogeneous group of diseases with varying ...
Povorcitinib 75 mg achieved high-threshold lesion clearance by week 12, including 100% draining-tunnel reduction in 12%–57% and total abscess clearance in 22%–62% of participants. Phase 3 data show ...
This study investigated the outcomes of perioperative multidisciplinary nursing collaboration for patients who underwent laparoscopic radical prostatectomy.
Researchers and clinicians from six leading medical centers and academic institutions—including the University of California San Diego—have collaborated to develop a new artificial intelligence model ...
I see commercials for it all the time, and the Amazon reviews were impressive (there are over 100,000 and counting), so it had to be good, right? I put it to the test on my clogged shower drain to ...
There are different ways to manage fatigue during prostate cancer treatment, including exercise, sleep, complementary ...
A new study using serial liquid biopsies to track how metastatic prostate cancer evolves under treatment pressure showed that ...
Lets examine what is draining your accounts and find a way to stop it from happening Donald Trump floats move to new state The economist who first warned of America's K-shaped recovery says this is ...
PCWorld reports that Microsoft has finally addressed the notorious Modern Standby battery drain issue plaguing Windows 11 devices. The fix in Windows 11 24H2 limits wake-up sources when high battery ...
Decades ago, doctors created a test to determine which breast cancer patients should receive hormone therapy. Now, researchers are using the same tactics to advance prostate cancer treatment. A recent ...
Wolinsky is a Chicago-based medical journalist and publisher of The Active Surveillor, a Substack newsletter that covers lower-risk prostate cancer and active surveillance. In 2002, at age 55, I ...